Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Vanderbilt Team's Discovery Offers New Insight on Lung Cancer Risk


 

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic "signature" from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.

Their findings, reported recently in the journal JCI Insight, are based on the observation that otherwise normal-looking cells in the epithelial lining of the lungs of heavy smokers and others at high risk for lung cancer undergo the same kind of "metabolic reprogramming" as do cancer cells.

To produce the extra lipids, nucleotides and amino acids they need to proliferate rapidly, cancer cells have to consume a lot of fuel, namely glucose. They essentially reverse the normal glucose-production cycle and "reprogram" their metabolism to increase uptake of glucose as well as glutamine, another quick-energy fuel.

The researchers discovered that normal cells in the lungs of heavy smokers do the same thing. The next step is to confirm that metabolic reprogramming is a "prerequisite for uncontrolled growth," said Jamshedur Rahman, PhD, research assistant professor of Medicine.

If so, metabolic reprogramming "would be a biomarker for risk," as well as an avenue for prevention, by targeting enzymes in metabolic pathways that lead to cancer, said senior author Pierre Massion, MD, Cornelius Vanderbilt Professor of Medicine and Cancer Biology.

"We're far from that target," said Massion, who directs the Cancer Early Detection and Prevention Initiative in the Vanderbilt-Ingram Cancer Center (VICC). "But this is a really exciting time for us."

Massion said the research could not have been done without major support from the National Cancer Institute (grant number CA152662) or the contributions of scientists across the University, including the paper's first authors, Rahman and research fellow Xiangming Ji, PhD.

Daniel Liebler, PhD, Ingram Professor of Cancer Research and director of the Jim Ayers Institute for Precancer Detection and Diagnosis at VICC, helped determine the "proteome," the unique set of proteins expressed in the lungs of cancer patients and those at high-risk for developing the disease.

Jamey Young, PhD, associate professor of Chemical and Biomolecular Engineering, developed software that enabled the researchers to track how glutamine was being used by epithelial cells.

Despite decades of attempts to thwart it, lung cancer remains the No. 1 cancer killer in the world, said Massion, who chairs the Lung Cancer Cooperative Group in the Early Detection Research Network, part of the National Cancer Institute.

"It's hard to stop a train that's going 200 miles an hour," he said. "We want to prevent this from gaining speed and, if possible, to ever get on the track."

 
Share:

Related Articles:


Recent Articles

Actuaries Examine How Changes to ACA Market Rules Would Affect Risk Adjustment

Proposals to alter the market rules applying to the individual and small group health insurance markets would likely require changing the Affordable Care Act's (ACA) risk adjustment program, the American Academy of Actuaries said in an issue brief published today.

Read More

Women to Watch Class of 2017

The women selected for the Class of 2017 are dedicated, talented, passionate, smart, collaborative innovators. In short, they are people we want to watch as leaders in their respective fields modeling ways to create a more efficient, effective healthcare system.

Read More

Fighting Breast Cancer with New Research, New Tools

New research, new tools bring new hope when it comes to preventing and treating breast cancer.

Read More

SMILE: New 3D Minimally Invasive Surgery for Myopia Makes Statewide Debut

A new minimally invasive procedure to treat myopia is something to SMILE about.

Read More

ONcology Rounds

News of note impacting cancer care.

Read More

New Take on an Old Disease

A multidisciplinary effort at The Saint Thomas Lung Cancer and Thoracic Center means more treatment choices for patients.

Read More

Prevent, Detect & Treat

Prevention of lung cancer and the science behind it are driving researchers at Vanderbilt-Ingram Cancer Center

Read More

The Science of Mental Health

Richard Shelton, MD, is on a mission to bring the latest medical breakthroughs to mental health patients faster than ever.

Read More

Study Highlights Higher Death Rate for Young People Experiencing an Incident Episode of Psychosis

A new study of all cause death in the 12 months following the first incidence of psychosis found a much higher than anticipated death rate in those ages 16-30.

Read More

Personalized Medicine & Lung Cancer

Genetics playing a significant role in the future of lung cancer treatment.

Read More

Email Print
 
 

 

 


Tags:
Jamshedur Rahman, Jim Ayers Institute for Precancer Detection and Diagnosis at VICC, lung cancer risk, Pierre Massion, Vanderbilt University
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: